Study Evaluating Gefitinib (IRESSA®) in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or Metastatic
Clinical trial NCT00127829 · COMPLETED
Trial details
- NCT number
- NCT00127829
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.